ArticleNature communications2025
Tuning evolvability via plasmid copy number and regulatory architecture.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genetic modules are often designed and implemented with inspiration from engineering disciplines. Although this approach can be successful because of the similarities underpinning physical and biochemical systems, it neglects a key factor that affects the performance of living organisms: evolution. Thus, it is crucial to incorporate the impact of inevitable mutations into the design and analysis of genetic modules. Combining computational modeling and in vivo mutagenesis experiments in Escherichia coli, we characterize how the interplay of gene dosage via plasmid copy number (PCN) and regulatory architecture affect the phenotypic mutation rate. For example, while greater PCN facilitates the emergence of gain-of-function mutations, it instead curbs the spread of loss-of-function mutations. We further reveal that mutations in the coding region are often masked at the phenotypic level, unlike those occurring in the regulatory region which become more prominent as PCN increases, both when the regulator is expressed constitutively and when it is self-repressed. Together, our results shed light on evolutionary organizing principles and aid the rational design of both evolutionarily stable and highly evolvable biocircuits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.